A detailed history of Inspire Trust Co, N.A. transactions in Biogen Inc. stock. As of the latest transaction made, Inspire Trust Co, N.A. holds 6,875 shares of BIIB stock, worth $1.2 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares
6,875
Previous 4,775 43.98%
Holding current value
$1.2 Million
Previous $1.03 Billion 54.79%
% of portfolio
0.53%
Previous 0.57%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$190.52 - $236.72 $400,092 - $497,112
2,100 Added 43.98%
6,875 $1.59 Billion
Q1 2024

May 15, 2024

BUY
$212.02 - $267.71 $530,050 - $669,275
2,500 Added 109.89%
4,775 $1.03 Billion
Q4 2023

Feb 14, 2024

BUY
$222.59 - $267.94 $506,392 - $609,563
2,275 New
2,275 $589 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Inspire Trust Co, N.A. Portfolio

Follow Inspire Trust Co, N.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Inspire Trust Co, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Inspire Trust Co, N.A. with notifications on news.